Health
Ronnie Cummins, Scourge of Genetically Modified Food, Dies at 76

Ronnie Cummins, a ponytailed activist who became one of the country’s leading advocates for organic food and a leading critic of genetically modified food, died on April 26 in San Miguel de Allende, Mexico, where he lived and worked part-time. He was 76.
Rose Welch, his wife and partner in starting the Organic Consumers Association, an advocacy and informational organization, said his death, which was not widely reported at the time, was caused by bone and lymph cancer.
Mr. Cummins was a lifelong activist and protester, beginning with his opposing the Vietnam War and nuclear power. He settled on organic food activism in the 1990s after he was hired as a director of the Pure Food Campaign, a lobbying group that sought to broaden awareness of the dangers of genetically engineered food while pushing for responsible labeling and government testing.
Mr. Cummins worked in the field for the campaign, raising alarm at rallies and supermarkets about the perils of foods using genetically modified ingredients. He handed out leaflets, wrote opinion articles and answered consumers’ questions as a campaign spokesman.
He also worked for the Beyond Beef campaign, aimed at reducing beef consumption and promoting safer methods of cattle production. Both campaigns were founded by the environmental activist and social theorist Jeremy Rifkin.
Mr. Cummins “was a tough guy who could be an activist and also step back and do the intellectual homework behind what we were doing,” Mr. Rifkin said in a phone interview.
“Too often activists burn out after starting out with high expectations,” he added. “But Ronnie could write, research, reflect and be open to all points of view.”
One of Mr. Cummins’s frequent targets was recombinant bovine somatotropin, or bovine growth hormone, a genetically engineered hormone, produced by Monsanto, that stimulates milk production in cows.
On the first day that farmers were allowed to sell milk from cows injected with the hormone, in 1994, Mr. Cummins told The Associated Press that “if we don’t slow down the technology of change with genetically engineered additives, we will be making a very major mistake in terms of human health, animal health and the survival of family farms.”
He continued to rail about milk produced by hormone-treated cows after he and Ms. Welch started the Organic Consumers Association, based in Finland, Minn., in 1998.
“Recombinant bovine growth hormone is bad for dairy cows, literally burning them out in three or four years, causing terrible physical stress and a long list of medical problems including reproductive complications,” Mr. Cummins wrote in The Fresno Bee in 2008.
He relished battling with major brands. In 2001, he raised doubt about Starbucks’s promise not to use milk products with the hormone by asking to see its promise in writing. (The company eventually complied in 2007.) He warned about a “sneak attack engineered by the likes of Kraft, Dean Foods and Smucker’s.” To pressure companies using modified beet sugar, he threatened a protest against Hershey.
Though there are unresolved questions about the effect of genetically modified organisms on biodiversity, there is a near-universal consensus among scientists that genetically modified foods are safe to eat.
Most consumers do not share that view, however, a skepticism due in large part to the efforts of activists like Mr. Cummins.
The safety of genetically modified food “is like global climate change, where 99 percent of scientists believe in it,” Pamela Ronald, a plant pathology professor at the University of California, Davis, told The Roanoke Times in 2013.
She added, “You have scientists around the world who say genetically engineered crops are safe to eat — and then you have Ronnie Cummins.”
Mr. Cummins was born Adrian Alton Abel on Oct. 28, 1946, in Jefferson, Tex., about 20 miles from the Louisiana border. His father, Jack, was an accountant for Gulf Oil in Port Arthur, Texas, in the heart of the state’s oil industry. His mother, Elise (Stout) Abel, was a homemaker who died by suicide in 1951.
In his 20s, Adrian changed his name to Ronnie Cummins, the name of a boy who was also born in 1946 and who died in 1954. Ms. Welch said he changed his name because he feared reprisals from the Ku Klux Klan for his antiwar activities at Rice University in Houston, where he had majored in English and philosophy and graduated with a bachelor’s degree in 1969.
Ms. Welch said she did not know why her husband took the Cummins boy’s name in particular. She said he told her that he did not have a criminal record that he was seeking to hide with a new identity. His brother, Jack Abel Jr., said by phone that the story behind the name change “is so personal I can’t share it.”
In addition to his wife and brother, Mr. Cummins is survived by his son, Adrian Cummins Welch; and his sisters, Molly Travis and Bonnie Abel.
Adrian grew up among refineries and later recalled catching fish polluted by oil. But he also spent idyllic summers on his maternal grandparents’ farm, where he took care of animals and gathered eggs.
“My life experience has taught me that money rules and power corrupts, and that putting profits before people and environmental health is not only wrong but deadly,” he wrote in his book “Grassroots Rising: A Call to Action on Climate, Farming, Food and Green New Deal” (2020). “Organized grass-roots power can make a big difference,” he added, “whether we’re talking about public consciousness, marketplace pressure or politics and public policy.”
As a career, activism didn’t pay the bills, so he earned a living over the years as a newsstand owner at the University of Minnesota, the director of a food co-op in Burnsdale, Minn., outside Minneapolis, and a house painter. Ms. Welch waited tables.
“He was pretty much a hippie,” she said in a phone interview.
Both went to work for Mr. Rifkin in the 1990s, Mr. Cummins as a director, Ms. Welch as a campaign manager. They left to start the Organic Consumers Association, which supports enforcement of the U.S. Department of Agriculture’s organic food standards, produces educational material for organic consumers and businesses, and encourages public pressure campaigns on organic food issues.
The “hippie” was finally earning a real salary — $112,900 in 2021.
The O.C.A. has spun off two organizations: the Mexico-based Via Orgánica, an agroecology farm school and research center, in 2009, and, in 2014, Regeneration International, which advances ways to develop farming practices that rebuild degraded soil.
In the view of André Leu, the international director of Regeneration International, Mr. Cummins had stood up to “the powerful elite who were monopolizing power and wealth” and were “undermining democracy, fair wages, healthy food, peace, the climate, and the environment.”
A longtime goal of Mr. Cummins’s was for the government to require labeling on genetically modified food. He fought for ballot initiatives in several states and won his first major victory in Vermont, in 2014, when it became the first state to pass a labeling law.
Faced with the prospect of a patchwork of state laws, Congress passed a sweeping federal labeling law in 2016.
But Mr. Cummins did not consider it a victory.
The law, which superseded the tougher Vermont legislation, gave companies the option of using an icon or a scannable QR code that would direct consumers to a website, instead of having to spell out the information on the package. And some foods, like highly refined sugars and oils, were exempt from the labeling requirement.
Mr. Cummins, in an article on his website, called brands like Organic Valley and Stonyfield Farms “organic traitors” and accused the Grocery Manufacturers Association, the Whole Foods supermarket chain “and a cabal of sellout, nonprofit organizations” of surrendering “to Monsanto and a corporate agribusiness” by backing the legislation.
“In other words business as usual,” he added, then used a buzzword for genetically modified products — “Shut up and eat your Frankenfoods.”
Sheelagh McNeill contributed research.

Health
Experts: How to Prevent Muscle Loss on Ozempic | Woman's World

Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Health
Alzheimer's disease could be prevented by antiviral drug already on market

An existing drug for HIV could double as a preventative therapy for Alzheimer’s disease, according to researchers.
NRTIs (nucleoside reverse transcriptase inhibitors) are antivirals that are approved to treat HIV infection, but scientists from UVA Health at the University of Virginia found that patients taking them were less likely to develop the common form of dementia.
There was a roughly 10% annual reduction in the risk of developing Alzheimer’s disease in people taking NRTIs for every year of use of these drugs, according to lead study author Dr. Jayakrishna Ambati, M.D., professor of ophthalmology at UVA, who spoke to Fox News Digital about the finding.
ALZHEIMER’S BRAIN TREATMENT SHOWS PROMISING RESULTS IN NEW STUDY
After coming across another mechanism that could potentially prevent Alzheimer’s, the researchers analyzed 24 years of health insurance data, including 270,000 patients.
The Alzheimer’s risk reduction among patients taking NRTIs was “significant and substantial,” the researchers wrote in the findings, which were published in the journal Alzheimer’s & Dementia.
An existing drug for HIV could double as a preventative therapy for Alzheimer’s disease, according to researchers. (iStock)
Now, the UVA team is calling for clinical trials of NRTIs to gauge their use for treating Alzheimer’s.
Approximately 10 million people worldwide are diagnosed with the common dementia each year.
ALZHEIMER’S RATES HAVE REACHED STAGGERING NUMBER AS EXPERTS CALL FOR CHANGE
“This level of protection could translate into 60,000 fewer cases of Alzheimer’s disease every year in our country, and up to one million fewer cases every year around the world,” Ambati told Fox News Digital.
In addition to keeping the HIV virus from replicating, NRTIs also prevent the activation of inflammasomes, proteins that are involved in the development of Alzheimer’s.

“This level of protection could translate into 60,000 fewer cases of Alzheimer’s disease every year in our country, and up to one million fewer cases every year around the world,” the lead study author told Fox News Digital. (iStock)
“We had previously shown that NRTIs blocked the inflammasome, so it wasn’t altogether surprising that people taking NRTIs might be protecting against this disease,” Ambati noted.
“However, the degree of protection against Alzheimer’s was quite surprising.”
“It is very possible that this drug may be useful in Alzheimer’s prevention.”
Dr. Marc Siegel, clinical professor of medicine at NYU Langone Health and Fox News senior medical analyst, was not involved in the study but commented on the findings.
“Inflammasomes are intracellular protein complexes that trigger the release of inflammatory cytokines,” he told Fox News Digital. “HIV uses these inflammasomes to fight the immune system.”

Repurposing existing drugs can offer a “promising pathway,” according to an expert from the Alzheimer’s Association. (iStock)
“These chemicals are likely responsible for making Alzheimer’s worse, or for accelerating the process of cognitive decline based on neuro-inflammation.”
Rebecca Edelmeyer, Ph.D., vice president of Scientific Engagement at the Alzheimer’s Association in Chicago, also reviewed the study’s findings, which she called “interesting.”
‘I’M A NEUROLOGIST — HERE’S WHY DEMENTIA IS RISING AND HOW TO REDUCE YOUR RISK’
“Further research and specifically designed clinical trials are needed to fully understand the potential future use of NRTIs to reduce the risk of Alzheimer’s, but the study highlights the potential role drug repurposing can play in advancing new Alzheimer’s treatments,” she told Fox News Digital.
Repurposing existing drugs can offer a “promising pathway,” according to Edelmayer. As existing drugs’ safety and side effects are often already known, the studies can be quicker and less expensive than with new treatments, she added.
Potential limitations and next steps
The research team acknowledged some limitations of the study.
“Like all retrospective health insurance database studies, the findings of our study are an association between this class of drugs and the development of Alzheimer’s disease,” Ambati told Fox News Digital.
“They don’t necessarily provide a cause and effect — however, the fact that we found this link in multiple databases increases confidence in this result.”
Siegel agreed that the new study is observational, but noted that it takes place over many years.
“It also shows that only this particular HIV drug — inflammasome — dramatically decreases the risk of Alzheimer’s, not the other HIV drugs, including protease inhibitors,” the doctor said.

Nearly seven million people in the U.S. are currently living with Alzheimer’s, and the number is expected to reach 13 million by 2050, according to the Alzheimer’s Association. (iStock)
“I think this is convincing preliminary evidence that warrants further study,” Siegel added. “It is very possible that this drug may be useful in Alzheimer’s prevention, given the increasing evidence implicating immune dysregulation and inflammation as causes of AD.”
Looking ahead, the researchers have developed a new drug called K9. Like NRTIs, the novel medication blocks inflammasomes, but is “safer and more effective,” according to Ambati.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“The fact that the new drug reversed memory loss and improved spatial learning in mice further increases confidence in our findings,” he told Fox News Digital.
The UVA team now plans to test K9 in clinical trials for Azheimer’s.

The study author cautioned that people should not take NRTIs for Alzheimer’s prevention unless they are in the context of a clinical trial. (iStock)
Ambati noted that people should not take NRTIs for Alzheimer’s prevention unless they are in the context of a clinical trial.
“If interested, they should be on the lookout for such trials for themselves or loved ones who may be affected,” he advised.
For more Health articles, visit www.foxnews.com/health
Nearly seven million people in the U.S. are currently living with Alzheimer’s, and the number is expected to reach 13 million by 2050, according to the Alzheimer’s Association.
The UVA study was funded in part by the UVA Strategic Investment Fund and the National Institutes of Health.
Health
Burn Belly Fat Fast With the New High-Protein Cabbage Soup Diet

Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
-
Austin, TX5 days ago
Best Austin Salads – 15 Food Places For Good Greens!
-
Technology1 week ago
Be careful what you read about an Elden Ring movie
-
Culture1 week ago
Pulitzer Prizes 2025: A Guide to the Winning Books and Finalists
-
Technology7 days ago
Netflix is removing Black Mirror: Bandersnatch
-
Education1 week ago
University of Michigan President, Santa Ono, Set to Lead University of Florida
-
World7 days ago
The Take: Can India and Pakistan avoid a fourth war over Kashmir?
-
News7 days ago
Reincarnated by A.I., Arizona Man Forgives His Killer at Sentencing
-
News1 week ago
Jefferson Griffin Concedes Defeat in N.C. Supreme Court Race